Alleged N109 Billion Fraud: Ex-director legal services admits signing ex-AGF statement as witness
A retired Director of Legal Services in the Office of the Accountant-General of the Federation, Haruna Alabi, on Tuesday admitted to signing the statement made by a former AGF, Ahmed Idris, as a witness on May 17, 2022.
Mr Alabi was testifying in the trial-within-trial of a former AGG in an federal High Court, Abuja, while being cross-examined by the prosecution counsel Oluwaleke Atolagbe.
The court had ordered a trial-within-trial following the objection raised by Mr Idris’ counsel, Chris Uche SAN.
Mr Uche objected on the grounds that the statements Mr Idris sought to tender on November 23, 2022, were made on the grounds of deception and inducement.
Mr Idris is charged alongside Geoffrey Akindele, Mohammed Usman and Gezawa Commodity Market and Exchange Limited with fraudulent diversion of public funds to the tune of N109.5 billion before Justice Halilu Yusuf.
They, however, pleaded not guilty to the charge.
Testifying, Mr Alabi identified his signature and name when the exhibit marked B3 (Idris’s statement from May 17, 2022) was shown to him.
When cross-examined by the prosecution counsel, Mr Atolagbe, the witness told the court that he visited Mr Idris at the Economic and Financial Crimes Commission (EFCC) headquarters on May 17, 2022, accompanied by other directors.
Asked if Mr Idris was still the AGF as of May 17, 2022, the witness stated he was in EFCC custody.
Asked in what capacity was their visit? He said, “As our former boss. We wanted to show empathy. I wrote my name and signed on the back of the 1st defendant‘s statement dated May 17, 2022, and did not sign any other space,” he said.
Asked if the 1st defendant wrote the statement he signed on the back on May 17, the witness replied, “I don’t know.”
After his evidence, the first defendant’s counsel asked for adjournment to enable him to produce his witness.
Mr Yusuf directed the defence to produce all his witnesses by the next adjourned date.
He then adjourned the continuation of the trial-within-trial until June 24.
(NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.
Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
Sport
2027 AFCON Qualifier: Guinea-Bissau beat Madagascar, extend lead over Nigeria in Group L
Guinea-Bissau now have 10 points, Nigeria seven points, while Madagascar and Tanzania have two points each.
Africa
WHO raises concern over rising Bundibugyo Ebola deaths, insecurity in DR Congo
Mr Ghebreyesus said the outbreak, declared six months ago, had spread across 67 health zones in eight provinces in the DR Congo.
Africa
Afreximbank urges industries to boost intra-African trade as alternative to China in global markets
“As global markets look to diversify production beyond China, Africa must position itself as a natural partner of choice,” Mr Maayergi said.
World
Russell Brand faces probe over prison message to supporters
Mr Brand was convicted at Southwark Crown Court of one count of rape and three counts of sexual assault.
Politics
Tinubu admits cost-of-living crisis after APC dismissed widespread hunger claims
According to Mr Tinubu, the 2027 election is about the country’s future and direction.
World
WHO pushes for stronger vaccination, screening, treatment to eliminate cervical cancer
WHO said that expanding HPV vaccination, improving screening access, and ensuring timely treatment are critical to protecting women.





